Hologic Inc. [NASDAQ: HOLX] price surged by 2.05 percent to reach at $1.38. The company report on June 23, 2021 that Hologic Receives European CE Mark for Molecular Assay to Quantify Human Cytomegalovirus.
–Aptima® CMV Quant Assay is Hologic’s first test for transplant pathogen monitoring–.
Hologic, Inc. (Nasdaq: HOLX) has received CE mark for its new Aptima® CMV Quant assay in Europe, the Company announced. This assay, which quantifies the viral load of human cytomegalovirus (CMV), is intended for use to aid in the diagnosis and management of solid-organ transplant patients and hematopoietic stem cell transplant patients. This in vitro nucleic acid amplification test (NAAT) uses real-time transcription-mediated amplification (TMA) technology on the fully automated Panther® system and can be used with human plasma and whole blood samples.
A sum of 4019555 shares traded at recent session while its average daily volume was at 2.48M shares. Hologic Inc. shares reached a high of $69.64 and dropped to a low of $67.50 until finishing in the latest session at $68.85.
The one-year HOLX stock forecast points to a potential upside of 16.97. The average equity rating for HOLX stock is currently 1.80, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Hologic Inc. [HOLX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOLX shares is $82.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOLX stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Hologic Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on November 20, 2020. While these analysts kept the previous recommendation, Needham raised their target price from $78 to $88. The new note on the price target was released on November 05, 2020, representing the official price target for Hologic Inc. stock. Previously, the target price had yet another raise to $64, while Cowen analysts kept a Outperform rating on HOLX stock.
The Average True Range (ATR) for Hologic Inc. is set at 1.35, with the Price to Sales ratio for HOLX stock in the period of the last 12 months amounting to 3.27. The Price to Book ratio for the last quarter was 4.69, with the Price to Cash per share for the same quarter was set at 3.23. Price to Free Cash Flow for HOLX in the course of the last twelve months was 9.61 with Quick ratio for the last quarter at 2.10.
HOLX Stock Performance Analysis:
Hologic Inc. [HOLX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.54. With this latest performance, HOLX shares gained by 9.18% in over the last four-week period, additionally sinking by -5.14% over the last 6 months – not to mention a rise of 29.10% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOLX stock in for the last two-week period is set at 73.44, with the RSI for the last a single of trading hit 84.25, and the three-weeks RSI is set at 64.23 for Hologic Inc. [HOLX]. The present Moving Average for the last 50 days of trading for this stock 64.94, while it was recorded at 66.34 for the last single week of trading, and 70.61 for the last 200 days.
Insight into Hologic Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Hologic Inc. [HOLX] shares currently have an operating margin of +30.47 and a Gross Margin at +58.62. Hologic Inc.’s Net Margin is presently recorded at +29.53.
Return on Total Capital for HOLX is now 20.76, given the latest momentum, and Return on Invested Capital for the company is 21.33. Return on Equity for this stock inclined to 46.27, with Return on Assets sitting at 16.35. When it comes to the capital structure of this company, Hologic Inc. [HOLX] has a Total Debt to Total Equity ratio set at 116.34. Additionally, HOLX Total Debt to Total Capital is recorded at 53.78, with Total Debt to Total Assets ending up at 43.74. Long-Term Debt to Equity for the company is recorded at 103.39, with the Long-Term Debt to Total Capital now at 47.79.
Reflecting on the efficiency of the workforce at the company, Hologic Inc. [HOLX] managed to generate an average of $191,813 per employee. Receivables Turnover for the company is 4.50 with a Total Asset Turnover recorded at a value of 0.55.Hologic Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.10 and a Current Ratio set at 2.60.
HOLX Stock EPS
With the latest financial reports released by the company, Hologic Inc. posted 0.75/share EPS, while the average EPS was predicted by analysts to be reported at 0.38/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 97.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOLX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hologic Inc. go to 2.35%.
Hologic Inc. [HOLX] Insider Position Details
There are presently around $16,236 million, or 97.40% of HOLX stock, in the hands of institutional investors. The top three institutional holders of HOLX stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 38,581,318, which is approximately -1.754% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 28,188,302 shares of the stock with an approximate value of $1.9 billion in HOLX stocks shares; and FMR LLC, currently with $1.87 billion in HOLX stock with ownership of nearly 4.73% of the company’s market capitalization.
Positions in Hologic Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 351 institutional holders increased their position in Hologic Inc. [NASDAQ:HOLX] by around 15,677,065 shares. Additionally, 266 investors decreased positions by around 17,202,986 shares, while 85 investors held positions by with 207,759,685 shares. The mentioned changes placed institutional holdings at 240,639,736 shares, according to the latest SEC report filing. HOLX stock had 86 new institutional investments in for a total of 752,259 shares, while 69 institutional investors sold positions of 4,358,566 shares during the same period.